RSSCategory: Ethics

Patient advocacy groups rake in donations from pharma

Patient advocacy groups rake in donations from pharma

By Emily Kopp Kaiser Health News High-profile advocacy groups for patients with cancer, Alzheimer’s, HIV and other diseases almost always accept funding from pharmaceutical firms, and many fail to report any contributions, new research shows. At least 83 percent of the nation’s 104 largest patient advocacy groups take contributions from the drug, medical device and […]

March 1, 2017 | By | Reply More
Big pharma quietly enlists leading professors to justify $1,000 per day drugs

Big pharma quietly enlists leading professors to justify $1,000 per day drugs

By Annie Waldman ProPublica Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an easy sell, because the price of the treatments ranges from $40,000 […]

February 23, 2017 | By | Reply More
Right-to-die fight hits national stage

Right-to-die fight hits national stage

By Melissa Bailey Kaiser Health News Opponents of aid-in-dying laws are claiming a small victory. They won the attention of Congress this week in their battle to stop a growing movement that allows terminally ill patients to get doctors’ prescriptions to end their lives. The Republican-led effort on Capitol Hill to overturn the District of Columbia’s […]

February 17, 2017 | By | Reply More
HHS pick Price made ‘brazen’ stock trades while his committee was under scrutiny

HHS pick Price made ‘brazen’ stock trades while his committee was under scrutiny

By Marisa Taylor and Christina Jewett Kaiser Health News Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading during the three years that federal investigators were bearing down on a key House committee on which the Republican congressman served, a review of his financial disclosures shows. Price made […]

February 8, 2017 | By | Reply More
Should scientists ask your permission to study your blood and tissues?

Should scientists ask your permission to study your blood and tissues?

The privacy debate over research with your blood and tissue – Viewpoint Kayte Spector-Bagdady, Research Investigator, Obstetrics and Gynecology University of Michigan Many people don’t realize that their leftover tissue, blood or other samples – otherwise known as “biospecimens” – taken during a visit to the doctor or hospital might be stripped of identifying information […]

January 27, 2017 | By | Reply More
Drug distributors penalized for turning blind eye in opioid epidemic

Drug distributors penalized for turning blind eye in opioid epidemic

By Charles Ornstein ProPublica As the toll of the opioid epidemic grows, scores of doctors have lost their licenses and some have gone to prison. Pharmacies are being sued and shuttered. Pharmaceutical manufacturers are under investigation and face new rules from regulators. But penalties against companies that serve as middlemen between drug companies and pharmacies […]

January 27, 2017 | By | Reply More
Trump’s HHS Choice: First a letter to Medicare. Then a campaign contribution.

Trump’s HHS Choice: First a letter to Medicare. Then a campaign contribution.

By Christina Jewett and Marisa Taylor Kaiser Health News Tom Price, the Georgia congressman tapped for the nation’s top health job, pressed Medicare officials on a funding change that led to a windfall for the small biotech company run by one of his top campaign contributors, according to a document released under an open records […]

January 24, 2017 | By | Reply More
Trump’s HHS pick favored drugmakers, device makers and doctors

Trump’s HHS pick favored drugmakers, device makers and doctors

By Christina Jewett and Marisa Taylor Kaiser Health News As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he interacted as a congressman with the Centers for Medicare and Medicaid, the massive agency he may soon oversee. Letters provided by CMS after […]

January 23, 2017 | By | Reply More
When study cast doubt on heart pill, the drug company turned to Tom Price

When study cast doubt on heart pill, the drug company turned to Tom Price

By Robert Faturechi ProPublica, Jan. 19, 2017 The $3 pill known as BiDil was already a difficult sell when a Georgia-based pharmaceutical company bought the marketing rights a few years ago. A treatment for African Americans suffering from heart failure, BiDil had never really caught on, forcing the drug company that developed it to take […]

January 20, 2017 | By | Reply More
A dying man’s wish to save others hits hospital ethics hurdle

A dying man’s wish to save others hits hospital ethics hurdle

By Karen Shakerdge, Side Effects Public Media Kaiser Health News At 44 years old, Dave Adox was facing the end of his two year battle with ALS, also known as Lou Gehrig’s disease. He needed a ventilator to breathe and couldn’t move any part of his body, except his eyes. Once he started to struggle […]

January 3, 2017 | By | Reply More